Immune to Cancer: The CRI Blog
-
Progress Report from the Cancer Immunology “Dream Team”
A group of "star" scientists are investigating new avenues of cancer immunotherapy that will benefit patients.
-
Do Something Epic in 2015!
Meet a few of the riders who will join Team CRI in the 2015 Ride to Conquer…
-
Patient Story Featured at World Cancer Congress
The inspiring story of lung cancer survivor Pam G. put a human face on cancer immunotherapy.
-
Phase 3 Trial of Nivolumab Shows Survival Advantage in Lung Cancer
The results of a phase III trial are clear: the PD-1 checkpoint inhibitor nivolumab improves survival for…
-
Could That Steak Be Giving You Cancer?
A CRI postdoctoral fellow was part of the team investigating the relation of red meat to cancer…
-
The Marathon to End All Marathons: The Great Wall of China Marathon with Emma Saunders
With her family ravaged by cancer, Emma wanted to do something huge to help conquer the disease….
-
CRI’s 2014 Blog in Review: Top 10
We reflect on our favorite blog posts of 2014, including FDA approvals, editorials, conference coverage, history, awards,…
-
Smart Giving this Holiday Season
Before you make your donation to any organization, take some time to learn about their charity ratings.
-
New Cancer Immunotherapy Opdivo Approved by FDA
Just hours ago, the FDA approved Bristol-Myers Squibb's PD-1 drug for melanoma.
Join CRI in Shaping the Future of Immunotherapy
Support the pioneering work of CRI in advancing immunotherapy.